Multipotent progenitor cells are present in human peripheral blood

Circulation Research

Volumn 104, Issue 10, 2009, Pages 1225-1234

  Cesselli, Daniela ^a   Beltrami, Antonio Paolo ^a   Rigo, Silvia ^a   Bergamin, Natascha ^a   D'Aurizio, Federica ^a   Verardo, Roberto ^b   Piazza, Silvano ^b   Klaric, Enio ^b   Fanin, Renato ^a   Toffoletto, Barbara ^a   Marzinotto, Stefania ^a   Mariuzzi, Laura ^a   Finato, Nicoletta ^a   Pandolfi, Maura ^a   Leri, Annarosa ^c   Schneider, Claudio ^b   Beltrami, Carlo Alberto ^a   Anversa, Piero ^c  

^a UNIVERSITY OF UDINE   (Italy)

^b National Biotechnology Laboratory (LNCIB)   (Italy)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Circulating progenitors; Gene expression profile; Multipotency; Stem cell plasticity; Stem cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BONE MARROW CELL; CELL CLONING; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CELL FUNCTION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GLIA CELL; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKAPHERESIS; LIVER CELL; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NERVE CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE STRUCTURE; BLOOD CELL; CYTOLOGY; DRUG EFFECT; METABOLISM;

BLOOD CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKAPHERESIS; MULTIPOTENT STEM CELLS;

EID: 66949155000     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.195859     Document Type: Article

References (38)

1. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005;115:572-583.
2. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells. A paradigm shift in cardiac biology. Circulation. 2006;113: 1451-1463.
3. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G, Yoon YS. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med. 2007;204:3257-3269.
4. Beltrami AP, Cesselli D, Bergamin N, Marcon P, Rigo S, Puppato E, D'aurizio F, Verardo R, Piazza S, Pignatelli A, Poz A, Baccarani U, Damiani D, Fanin R, Mariuzzi L, Finato N, Masolini P, Burelli S, Belluzzi O, Schneider C, Beltrami CA. Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow). Blood. 2007;110:3438-3446.
5. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71-81.
6. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol. 2001;153:1133-1140.
7. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A. 2003;100:2426-2431.
8. He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25:69-77.
9. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res. 2008;102:1319-1330.
10. Verfaille CM. Adultstem cells: tissue specific or not? In: Lanza R, Blau H, Melton DA, Moore M, Thomas ED, Verfaillie C, Weissman I, West M, eds. Handbook of Stem Cells. Burlington, Mass: Elsevier Academic Press; 2004:13-20.
11. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
12. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D'alessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P. Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007;104:14068-14073.
13. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
14. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003; 4:R70.
15. Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, Parmigiani G, Berman DM. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008;27:7180-7191.
16. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122:947-956.
17. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116: 639-648.
18. Roufosse CA, Direkze NC, Otto WR, Wright NA Circulating mesen-chymal stem cells. Int J Biochem Cell Biol. 2004;36:585-597.
19. Fox JM, Chamberlain G, Ashton BA, Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol. 2007;137:491-502.
20. Cashen AF, Lazarus HM, Devine SM. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? Bone Marrow Transplant. 2007;39:577-588.
21. Ripa RS, Haack-Sorensen M, Wang Y, Jorgensen E, Mortensen S, Bindslev L, Friis T, Kastrup J. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation. 2007;116(suppl I):I-24-I-30.
22. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
23. Kolonin MG, Simmons PJ. Combinatorial stem cell mobilization. Nat Biotechnol. 2009;27:252-253.
24. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The che-mokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185: 111-120.
25. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V, Slav MM, Nagler A, Lider O, Alon R, Zipori D, Lapidot T. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood. 2000;95:3289-3296.
26. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111:187-196.
27. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 2009;4:62-72.
28. Spitzer G, Adkins D, Mathews M, Velasquez W, Bowers C, Dunphy F, Kronmueller N, Niemeyer R, McIntyre W, Petruska P. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy. Bone Marrow Transplant. 1997;20:921-930.
29. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D, Rafii S. Placental growth factor reconstitutes hema-topoiesis by recruiting VEGFR1( + ) stem cells from bone-marrow micro-environment. Nat Med. 2002;8: 841 - 849.
30. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820-827.
31. Fiedler J, Brill C, Blum WF, Brenner RE. IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun. 2006;345:1177-1183.
32. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, Czajka R, Wojakowski W, Machalinski B, Ratajczak MZ. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia. 2007;21:297-303.
33. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
34. Greco SJ, Liu K, Rameshwar P. Functional similarities among genes regulated by Oct4 in human mesenchymal and embryonic stem cells. Stem Cells. 2007;25:3143-3154.
35. Doherty JM, Geske MJ, Stappenbeck TS, Mills JC. Diverse adult stem cells share specific higher-order patterns of gene expression. Stem Cells. 2008;26:2124-2130.
36. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science. 2002;298:597-600.
37. Huss R, Lange C, Weissinger EM, Kolb HJ, Thalmeier K. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells. 2000;18:252-260.
38. Quesenberry PJ, Colvin GA, Lambert J-F. The chiaroscuro stem cell: a unified stem cell theory. Blood. 2002;100:4266-4271.